Aptevo Therapeutics APVO
NASDAQ APVO
$1.76 +0.00 (+0.00%)
At close: Oct 2, 2026 · 4:00 PM EDT

Aptevo Therapeutics (APVO) Return on Equity [ROE] (2016 - 2026)

Updated

Aptevo Therapeutics (APVO) posted Return on Equity [ROE] of -302.03% for Q2 2026, up 649.26 percentage points from -951.30% a year earlier but down 119.18 percentage points from the prior quarter.

Analysis

Aptevo Therapeutics (APVO) Return on Equity [ROE] (2016 - 2026) Analysis & Trends

For FY2025, Aptevo Therapeutics' Return on Equity [ROE] came in at -234.61%, up 49.67 percentage points from FY2024.

  • Annual Return on Equity [ROE] shows a five-year change of -109.77 percentage points (FY2020 to FY2025).
  • In prior years, Aptevo Therapeutics' Return on Equity [ROE] was -284.28% in FY2024 (-168.96 pp), -115.32% in FY2023 (-198.98 pp), 83.66% in FY2022 (+403.22 pp) and -319.56% in FY2021 (-194.72 pp).
  • Quarterly Return on Equity [ROE] has run from a low of -1444.49% in Q1 2025 to a high of 89.73% in Q1 2023 over five years.
  • On a year-over-year basis, Return on Equity [ROE] has increased in each of the last four quarters, with an average year-over-year change of +17.91 percentage points over the last eight quarters.
  • The strongest year-over-year quarter for Return on Equity [ROE] in the past five years was Q1 2026, with a gain of 1261.63 percentage points; the weakest was Q1 2025, with a drop of 1149.58 percentage points.
  • According to Business Quant data, Return on Equity [ROE] for the three prior quarters was -182.85% (Q1 2026), -150.80% (Q4 2025) and -221.89% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROE (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 82.09%
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 25.32%
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 7.21%
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 84.40%
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 21.39%
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 83.75%
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -18.38%
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 4.97%
10 Aptevo Therapeutics 2.50 Mn -64.50 Mn - -302.03%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -302.03%
Mar 31, 2026 -182.85%
Dec 31, 2025 -150.80%
Sep 30, 2025 -221.89%
Jun 30, 2025 -951.30%
Mar 31, 2025 -1,444.49%
Dec 31, 2024 -525.99%
Sep 30, 2024 -534.08%
Jun 30, 2024 -472.35%
Mar 31, 2024 -294.90%
Dec 31, 2023 -129.27%
Sep 30, 2023 -104.30%
Jun 30, 2023 -88.39%
Mar 31, 2023 89.73%
Dec 31, 2022 47.59%
Sep 30, 2022 32.97%
Jun 30, 2022 82.08%
Dec 31, 2021 -668.95%
Sep 30, 2021 -276.18%
Jun 30, 2021 -238.11%
API Access

Aptevo Therapeutics Return on Equity [ROE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=APVO&period=max&api_key=YOUR_API_KEY